Clinical Trial

Genomic Markers Predictive of Uterine Atony

Study Description

Exploration and Determination of Genomic Markers Predictive of Uterine Atony

The primary objective of this study is to determine whether there are markers in the tissue of atonic uteri, and in the patients' plasma that would help identify patients likely to suffer postpartum hemorrhage due to uterine atony. We also will attempt to identify the cause(s) of uterine atony that might suggest mechanisms to prevent and manage it.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Analysis of genomic markers in uterine atony

No intervention will be performed. We will be analyzing tissue and blood samples only to identify potential association of genomic markers with uterine atony.

Additional Information

Official Study Title

Exploration and Determination of Genomic Markers Predictive of Uterine Atony

Clinical Trial ID

NCT03413917

ParticipAid ID

YaO3Ba